Hercules Capital ROE 2010-2023 | HTGC
Current and historical return on equity (ROE) values for Hercules Capital (HTGC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Hercules Capital ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$0.34B |
$1.80B |
20.67% |
| 2023-09-30 |
$0.28B |
$1.65B |
18.31% |
| 2023-06-30 |
$0.31B |
$1.59B |
20.93% |
| 2023-03-31 |
$0.20B |
$1.50B |
14.38% |
| 2022-12-31 |
$0.10B |
$1.40B |
7.59% |
| 2022-09-30 |
$0.04B |
$1.36B |
3.30% |
| 2022-06-30 |
$0.02B |
$1.33B |
1.13% |
| 2022-03-31 |
$0.11B |
$1.33B |
8.10% |
| 2021-12-31 |
$0.18B |
$1.31B |
13.16% |
| 2021-09-30 |
$0.32B |
$1.34B |
24.30% |
| 2021-06-30 |
$0.34B |
$1.36B |
26.56% |
| 2021-03-31 |
$0.32B |
$1.32B |
25.89% |
| 2020-12-31 |
$0.23B |
$1.29B |
19.21% |
| 2020-09-30 |
$0.12B |
$1.17B |
10.60% |
| 2020-06-30 |
$0.10B |
$1.16B |
8.66% |
| 2020-03-31 |
$0.08B |
$1.10B |
7.51% |
| 2019-12-31 |
$0.17B |
$1.13B |
16.04% |
| 2019-09-30 |
$0.11B |
$1.09B |
10.74% |
| 2019-06-30 |
$0.13B |
$1.11B |
12.53% |
| 2019-03-31 |
$0.13B |
$0.99B |
13.39% |
| 2018-12-31 |
$0.08B |
$0.96B |
8.10% |
| 2018-09-30 |
$0.11B |
$1.00B |
12.20% |
| 2018-06-30 |
$0.11B |
$0.96B |
12.56% |
| 2018-03-31 |
$0.09B |
$0.83B |
10.83% |
| 2017-12-31 |
$0.08B |
$0.84B |
9.45% |
| 2017-09-30 |
$0.07B |
$0.84B |
9.11% |
| 2017-06-30 |
$0.07B |
$0.82B |
8.97% |
| 2017-03-31 |
$0.05B |
$0.81B |
6.13% |
| 2016-12-31 |
$0.07B |
$0.79B |
9.00% |
| 2016-09-30 |
$0.07B |
$0.75B |
9.22% |
| 2016-06-30 |
$0.04B |
$0.72B |
5.70% |
| 2016-03-31 |
$0.03B |
$0.72B |
4.69% |
| 2015-12-31 |
$0.04B |
$0.72B |
5.56% |
| 2015-09-30 |
$0.05B |
$0.72B |
6.51% |
| 2015-06-30 |
$0.06B |
$0.74B |
8.22% |
| 2015-03-31 |
$0.07B |
$0.76B |
10.08% |
| 2014-12-31 |
$0.07B |
$0.66B |
10.66% |
| 2014-09-30 |
$0.08B |
$0.66B |
11.46% |
| 2014-06-30 |
$0.10B |
$0.66B |
14.89% |
| 2014-03-31 |
$0.11B |
$0.65B |
16.36% |
| 2013-12-31 |
$0.10B |
$0.65B |
15.65% |
| 2013-09-30 |
$0.10B |
$0.64B |
16.52% |
| 2013-06-30 |
$0.07B |
$0.62B |
11.88% |
| 2013-03-31 |
$0.05B |
$0.62B |
8.67% |
| 2012-12-31 |
$0.05B |
$0.52B |
9.46% |
| 2012-09-30 |
$0.04B |
$0.47B |
8.17% |
| 2012-06-30 |
$0.04B |
$0.48B |
8.83% |
| 2012-03-31 |
$0.06B |
$0.49B |
14.53% |
| 2011-12-31 |
$0.05B |
$0.43B |
10.95% |
| 2011-09-30 |
$0.04B |
$0.42B |
9.87% |
| 2011-06-30 |
$0.03B |
$0.42B |
6.84% |
| 2011-03-31 |
$-0.00B |
$0.40B |
-0.53% |
| 2010-12-31 |
$0.01B |
$0.41B |
1.36% |
| 2010-09-30 |
$0.00B |
$0.34B |
0.28% |
| 2010-06-30 |
$0.02B |
$0.35B |
6.05% |
| 2010-03-31 |
$0.01B |
$0.37B |
3.82% |
| 2009-12-31 |
$0.01B |
$0.37B |
3.23% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$3.076B |
$0.461B |
|
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|
